Fenograf S 360mg Tablet contains Mycophenolate sodium 360mg, an immunosuppressive agent primarily used to prevent organ rejection in transplant patients. It works by inhibiting the proliferation of T and B lymphocytes, which play a critical role in the immune response, thereby reducing the likelihood of the body attacking the transplanted organ. Fenograf S is commonly prescribed following kidney, heart, or liver transplantation to improve graft survival rates. The medication is typically administered orally and should be taken exactly as directed by a healthcare professional to ensure optimal efficacy and minimize adverse effects. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain, as well as increased susceptibility to infections due to immune suppression. Patients are advised to report any unusual symptoms, signs of infection, or allergic reactions promptly. Regular monitoring of blood counts and kidney function is essential during therapy to detect potential complications early. Fenograf S should not be used during pregnancy unless clearly needed, as it may cause harm to the fetus. It is important to inform the doctor about any other medications being taken to avoid potential drug interactions. Overall, Fenograf S 360mg Tablet is a vital medication in transplant medicine, helping to maintain organ function and improve patient outcomes.